Described herein are pharmaceutical packaging methods which reduce oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive medication, such programs together with a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely lower permeability to oxygen an